204 related articles for article (PubMed ID: 36965094)
1. Psychological distress is involved in CRCI in breast cancer survivors via mediating cytokine levels.
Pang L; Li W; Yao S; Jing Y; Yin X; Cheng H
Cancer Med; 2023 May; 12(10):11806-11815. PubMed ID: 36965094
[TBL] [Abstract][Full Text] [Related]
2. Changes in cytokine levels in breast cancer patients with CRCI before or after CALM intervention.
Pang L; Bi Z; Jing Y; Yin X; Zhang X; Yao S; Zhao J; Cheng H
Am J Cancer Res; 2021; 11(11):5415-5427. PubMed ID: 34873469
[TBL] [Abstract][Full Text] [Related]
3. Changes in plasma IL-1β, TNF-α and IL-4 levels are involved in chemotherapy-related cognitive impairment in early-stage breast cancer patients.
Zhao J; Zuo H; Ding K; Zhang X; Bi Z; Cheng H
Am J Transl Res; 2020; 12(6):3046-3056. PubMed ID: 32655829
[TBL] [Abstract][Full Text] [Related]
4. Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors.
Ding K; Zhang X; Zhao J; Zuo H; Bi Z; Cheng H
Integr Cancer Ther; 2020; 19():1534735420938450. PubMed ID: 32683997
[No Abstract] [Full Text] [Related]
5. The correlation between neutrophil-to-lymphocyte ratio, carcinoembryonic antigen, and carbohydrate antigen 153 levels with chemotherapy-related cognitive impairment in early-stage breast cancer patients.
Yu S; Zhao J; Wang M; Cheng G; Li W; Tang L; Yao S; Pang L; Yin X; Jing Y; Cheng H
Front Med (Lausanne); 2022; 9():945433. PubMed ID: 36091709
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy-related Cognitive Impairment and Quality of Life in People with Colon Cancer: The Mediating Effect of Psychological Distress].
Oh PJ; Kim JH
J Korean Acad Nurs; 2016 Feb; 46(1):19-28. PubMed ID: 26963411
[TBL] [Abstract][Full Text] [Related]
7. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer.
Lyon DE; Cohen R; Chen H; Kelly DL; McCain NL; Starkweather A; Ahn H; Sturgill J; Jackson-Cook CK
J Neuroimmunol; 2016 Dec; 301():74-82. PubMed ID: 27890459
[TBL] [Abstract][Full Text] [Related]
8. Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment.
Yap NY; Toh YL; Tan CJ; Acharya MM; Chan A
Cytokine; 2021 Aug; 144():155556. PubMed ID: 33985854
[TBL] [Abstract][Full Text] [Related]
9. Distress, proinflammatory cytokines and self-esteem as predictors of quality of life in breast cancer survivors.
Perez-Tejada J; Aizpurua-Perez I; Labaka A; Vegas O; Ugartemendia G; Arregi A
Physiol Behav; 2021 Mar; 230():113297. PubMed ID: 33352145
[TBL] [Abstract][Full Text] [Related]
10. Serum tumor necrosis factor-α, interleukin-1β, interleukin-6, and interleukin-17 relate to anxiety and depression risks to some extent in non-small cell lung cancer survivor.
Liu M; Li Y; Liu X
Clin Respir J; 2022 Feb; 16(2):105-115. PubMed ID: 34697903
[TBL] [Abstract][Full Text] [Related]
11. Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients.
Chae JW; Ng T; Yeo HL; Shwe M; Gan YX; Ho HK; Chan A
PLoS One; 2016; 11(10):e0164204. PubMed ID: 27701469
[TBL] [Abstract][Full Text] [Related]
12. Role of Cytokines in Chemotherapy-related Cognitive Impairment of Breast Cancer Patients: A Systematic Review.
Tyagi K; Masoom M; Majid H; Garg A; Bhurani D; Agarwal NB; Khan MA
Curr Rev Clin Exp Pharmacol; 2023; 18(2):110-119. PubMed ID: 35249524
[TBL] [Abstract][Full Text] [Related]
13. Active and Passive Coping Strategies: Comparing Psychological Distress, Cortisol, and Proinflammatory Cytokine Levels in Breast Cancer Survivors.
Perez-Tejada J; Garmendia L; Labaka A; Vegas O; Gómez-Lazaro E; Arregi A
Clin J Oncol Nurs; 2019 Dec; 23(6):583-590. PubMed ID: 31730606
[TBL] [Abstract][Full Text] [Related]
14. Self-reported cognitive impairment in cervical cancer survivors: A cross-sectional study.
Areklett EW; Fagereng E; Bruheim K; Andersson S; Lindemann K
Psychooncology; 2022 Feb; 31(2):298-305. PubMed ID: 34516040
[TBL] [Abstract][Full Text] [Related]
15. Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting-state fMRI.
Yao S; Zhu Q; Zhang Q; Cai Y; Liu S; Pang L; Jing Y; Yin X; Cheng H
Cancer Med; 2023 Aug; 12(15):16231-16242. PubMed ID: 37409628
[TBL] [Abstract][Full Text] [Related]
16. Within-person changes in cancer-related distress predict breast cancer survivors' inflammation across treatment.
Renna ME; Shrout MR; Madison AA; Alfano CM; Povoski SP; Lipari AM; Agnese DM; Carson WE; Kiecolt-Glaser JK
Psychoneuroendocrinology; 2020 Nov; 121():104866. PubMed ID: 32947247
[TBL] [Abstract][Full Text] [Related]
17. The impact of mindfulness on cancer-related cognitive impairment in breast cancer survivors with cognitive complaints.
Melis M; Schroyen G; Leenaerts N; Smeets A; Sunaert S; Van der Gucht K; Deprez S
Cancer; 2023 Apr; 129(7):1105-1116. PubMed ID: 36625501
[TBL] [Abstract][Full Text] [Related]
18. Cancer-Related Cognitive Impairment in Breast Cancer Patients: Influences of Psychological Variables.
Yang Y; Hendrix CC
Asia Pac J Oncol Nurs; 2018; 5(3):296-306. PubMed ID: 29963592
[TBL] [Abstract][Full Text] [Related]
19. Aldehyde dehydrogenase 2 polymorphism is associated with chemotherapy-related cognitive impairment in patients with breast cancer who receive chemotherapy.
Yao S; Li W; Liu S; Cai Y; Zhang Q; Tang L; Yu S; Jing Y; Yin X; Cheng H
Cancer Med; 2023 Mar; 12(5):5209-5221. PubMed ID: 36200595
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and associated factors of chemotherapy-related cognitive impairment in older breast cancer survivors.
Zhou X; Zhang X; Zhong T; Zhou M; Gao L; Chen L
J Adv Nurs; 2024 Feb; 80(2):484-499. PubMed ID: 37675947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
